Federal Officials to Tighten Access to Potentially Abusive Drugs
By Physician’s Briefing Staff HealthDay Reporter
New Requirements for Opioid Painkillers and ADHD Drugs
The Biden administration plans to reinstate federal prescribing requirements that were relaxed during the pandemic. Patients seeking a first prescription for opioid painkillers and ADHD drugs like Adderall and Ritalin will now be required to see a doctor in person, rather than through telehealth appointments. However, prescription refills will still be allowed during telehealth appointments.
Tightening Prescribing for Less Addictive Drugs
The U.S. Drug Enforcement Administration will also tighten prescribing for less addictive drugs such as codeine, Xanax, Ambien, and buprenorphine. Patients will be allowed to receive a 30-day dose via telehealth for these drugs, but will then need to see a doctor in person for a refill. This new rule is expected to take effect before May 11, when the COVID-19 public health emergency expires.
DEA’s Commitment to Safe Telemedicine
DEA Administrator Anne Milgram stated that the agency is committed to ensuring that all Americans can access needed medications. The DEA plans to expand telemedicine with guardrails that prevent the online overprescribing of controlled medications that can cause harm.
Planning Ahead for Doctor Visits
Patients needing these medications should plan for a visit to a doctor before the new rule takes effect, which may be a bigger barrier for those living in rural areas. Patients will need to see their doctor in person within six months after the rule goes into effect.
Prescriptions Still Allowed Through Telehealth Appointments
Common prescriptions such as birth control, antibiotics, insulin, and skin creams will still be allowed to be prescribed through telehealth appointments.
More Information © 2023 HealthDay. All rights reserved. Posted February 2023